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1. Introduction 
1.1 Implantation failure in endometriosis 
The process of implantation is an interactive cascade of events between the embryo and the 
endometrium. It is a dynamic process consisting of three distinct phases. They are (i) 
apposition of embryo (ii)  attachment with the epithelial lining of the endometrium and  (iii)  
invasion into the endometrial stroma gaining access to the maternal circulatory system. 
Embryo implantation failure may occur due to embryonic defect or unsupportive 
endometrium. Advances in Assisted Reproductive Technology (ART) have made it possible 
to obtain good quality embryos; however, successful implantation remains the bottleneck 
for a successful pregnancy. The endometrium remodels before attaining a state of 
receptivity. Endometrium remains receptive during a limited period, when it is favourable 
for blastocyst attachment and implantation. In women, there is clinical evidence of a brief 
period of optimal uterine receptivity which allows for blastocyst implantation. This period, 
called the implantation window, is related to changes in the endometrial epithelial 
morphology. Inappropriate morphological development leads to unreceptive endometrium 
that causes defective endometrial /embryonic cross talk. This is generally agreed to be one 
of the main reasons for implantation failure. Endometriosis, characterized by benign growth 
of endometrial tissue outside the uterus, affects approximately 20%–48% of women during 
their reproductive years. The occurrence of aberrant hormonal, immunological, genetic and 
pathophysiological events associated with endometriosis is attributed to the heterogeneous 
etiology of the disease. The symptoms of endometriosis do not depend on the severity or 
stage of the disease. Women with even mildest degree of endometriosis can have a 3 – 4 fold 
reduction in their annual birth rate compared to normal non-endometriotic women. 
Presence of endometriosis alters the characteristic of the endometrium. It also affects the 
expression of various factors and markers of receptivity during implantation window. All 
these result in dysfunctional endometrium. This can be a cause of higher implantation 
failure rates and lower pregnancy rates in endometriotic women due to failure of embryo 
implantation. However, alterations in endometrial remodeling in endometriosis resulting in 
impairment of the endometrial receptivity is still poorly understood. An understanding of 
endometrial receptivity in women with endometriosis is, therefore, crucial in understanding 
the fundamental causes of implantation failure which in turn, may have significant 
implications on fertility potential of these women. 
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2. Matrix turnover and angiogenesis during implantation 
2.1 Matrix turnover in endometrium and implantation 
The unique characteristic of the endometrial tissue is that it undergoes cyclic degeneration 
and regeneration in each menstrual cycle. The endometrium consists of a layer of columnar 
epithelium bedded on a layer of connective tissue. The extracellular matrix (ECM), which 
forms a component of the connective tissue, provides the scaffolding for the anchorage of 
the cells within the tissue (McIntush and Smith 1998) and presents a locale for cellular 
migration, division and differentiation (Birkedal-Hansen et al., 1993). The extensive 
remodeling of the connective tissue of the endometrium requires both the degradation and 
reformation of the ECM which is accomplished by highly regulated turnover of the ECM 
(Hulboy et al., 1997). This destruction of the ECM occurs by the action of a class of 
proteolytic enzyme identified as matrix metalloproteinases (MMP). MMPs and the tissue 
inhibitors of metalloproteinases (TIMP) regulate a number of aspects of reproductive 
physiology like dynamic remodeling of the ovary and endometrium throughout each 
menstrual cycle, implantation, embryonic development and parturition. There exists 
equilibrium between the MMPs and TIMPs action for controlling this turnover of the ECM. 
Any circumstances that may bring about interruption of this delicate balance leads to a 
number of pathological complexities related to pregnancy and infertility like luteinized 
unruptured follicle syndrome, ovarian cysts, endometriosis, uterine fibroids, inappropriate 
implantation resulting in tubal pregnancy or spontaneous abortion, premature rupture of 
fetal membranes, or carcinoma of the ovary or uterus (Curry and Osteen 2003). 
Several studies have reported the diverse pattern of MMPs expression in the endometrium 
throughout the menstrual cycle. Since breakdown of the endometrial lining occurs during 
menstruation, several MMPs are reported to be highly expressed during this phase. 
However, their expression gradually falls off during rest of the cycle. Nevertheless various 
MMPs are observed to express at various phases of the cycling endometrium. Expression of 
MMP-2 remains consistent throughout the whole cycle along with TIMP-1 and TIMP-2. 
Endometrial MMP-9 expression shows a cyclical change in its distribution between 
glandular and stromal cells. It expresses in the endometrium throughout the cycle, however, 
its expression increases during midsecretory phase particularly in the glandular cells 
(Hulboy et al., 1997). Although the association of MMP-2 and -9 and their endogenous 
inhibitors in pathogenesis of infertile condition like endometriosis is well established (Salata 
et al., 2008), knowledge regarding their involvement in endometrial remodelling during 
implantation window in endometriotic women is limited.  
2.2 Angiogenesis 
Endometrial remodeling involves proliferation of its functional layer upon estrogen 
enhancement (Groothuis et al., 2007) and differentiation by the influence of progesterone 
from the luteinized follicles (Okada et al., 1999). This is followed by the degeneration of this 
superficial layer and again reconstruction of the new one. These constant cyclic changes of 
the endometrium are associated with angiogenesis and neovascularisation (Perrot-Applanat 
et al., 2000). Vascular endothelial growth factor (VEGF) is a prime angiogenic stimulus for 
vascular permeability based on its capability to bring on vascular leakage (Ferrara and 
Davis-Smyth 1997, Ferrara et al., 2003). VEGF regulated angiogenesis and neovasculogenesis 
of the endometrial tissue is elemental for the growth and differentiation of the endometrium 
for implantation and placentation (Giudice 1996, Perrot-Applanat 2000). Due to its control 
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over the human reproductive cycle, VEGF is present in the stromal and glandular 
epithelium of the human endometrium throughout all phases of the menstrual cycle (Torry 
and Torry 1997, Smith 1998, Shifren et al., 1996, Charnock-Jones 1993, Popovici 1999, 
Lockwood 2002). However there exists a strong debate regarding its expression and 
angiogenesis. VEGF expression increased in the late secretory phase and heightened during 
menses (Torry and Torry 1997, Charnock-Jones 1993, Popovici 1999, Lockwood 2002, 
Bausero 1998). There is a marked increase even in the vascular network of the endometrium 
during the secretory phase over the proliferative phase (Ota 1998). But Nayak and Brenner 
reported that during proliferative phase there is a noted increase in the VEGF expression in 
stroma which shifts to glandular epithelium during the secretory phase (Nayak and Brenner 
2002). However, contradictory report exist indicating that a gradual decline in angiogenesis 
occurs at the end of the cycle which rapidly increases with the start of a new cycle and 
reaching a maximum height during the mid cycle (Au and Rogers 1993). Other investigators 
have suggested that VEGF expression remains inconsistent (Sugino et al., 2002) or there is 
no change in the vascularity throughout the endometrial cycle (Rogers and Au 1993). 
2.3 Regulation of matrix remodeling 
It is suggested that inappropriate regulation of sex steroids may lead to defect in 
implantation. The role of estradiol in embryo implantation is a subject of controversy and its 
association with pregnancy outcome in IVF cycle is an area of research for many years 
(Kyrou et al 2009). Several studies have shown that midluteal decline of serum estradiol do 
not affect the endometrial development, embryo implantation and IVF outcome (Friedler et 
al., 2005; Narvekar et al., 2010; Hung et al., 2000). This may be due to the fact that during 
follicular phase, estradiol induces growth of follicles, preparation of endometrium and 
production of specific proteins, growth factors and receptors of estrogen and progesterone. 
Additionally, adverse effect of high estradiol level on endometrial receptivity is still under 
debate (Kyrou et al., 2009). A number of investigators found no effect of high estradiol levels 
on the treatment outcome of IVF/ICSI cycle (Sharara and McClamrock 1999, Kosmas et al., 
2004). Some studies have, however, suggested that elevated levels of estradiol may be 
responsible for impaired endometrial receptivity (Simon et al., 1995; Valbuena et al., 2001; 
Kyrou et al., 2009). After ovulation, progesterone is the main contributory sex hormone 
executing the transformation of the endometrium during the secretory phase. 
It is evidenced that expression of cyclooxygenase-2 (COX-2), a molecule associated with 
angiogenesis and cell differentiation, promotes the release of MMP-2 (Xiong et al., 2005) and 
-9 (Itatsu et al., 2009),  and angiogenic factor VEGF (Wang et al. (2010).  COX-2, on the other 
hand, is regulated by female sexual hormone estradiol and progesterone (Li et al., 2007). 
Since the process of angiogenesis during endometrial remodelling shares similarities with 
the process of angiogenesis during metastasis in cancer, estradiol may also be involved in 
the up-regulation of the gene expression of COX-2 and MMPs during embryo implantation. 
Involvement of COX-2 gene in embryo implantation is a subject of interest among the 
researchers working on endometrial receptivity, and is suggested to play an important 
regulatory role in successful implantation. However, little is known about its role in 
endometrial receptivity in women with endometriosis. 
2.4 Endometrial receptivity markers 
Inadequate uterine receptivity and poor embryo formation are two major factors responsible 
for implantation failure (Simon et al., 1998; Ledee-Bataille et al., 2002). Nowadays, using 
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ART procedure, clinicians can improve embryo formation considerably; however, no 
therapies are available to make the endometrium more receptive. Expression of various 
implantation markers and proteins lead to remodeling of the endometrial matrix thereby 
transforming the endometrium towards a receptive milieu. Several molecular repertoires 
expressed during the implantation window are considered to be useful markers of 
implantation. Expression of various markers including pinopodes ǂvǃ3 integrin, LIF, L-
selectin ligand and Mucin-1 throughout the different stages of implantation are considered 
to be responsible for endometrial receptivity.  
2.4.1 Pinopodes  
Pinopodes, also known as uterodomes, are large cytoplasmic protrusions from the 
endometrial epithelial surface and are several micrometers wide. These are specialized cell 
structures that are involved in adhesion and penetration of the blastocyst into the stroma. 
These structures project into the uterine lumen and are above the microvilli level. Their 
expression is limited to a maximum period of 2 days during the menstrual cycle 
corresponding to the presumed window of implantation (Stavreus-Evers et al., 2001). 
Endometrial pinopodes development is associated with the mid-luteal phase increased 
expression of leukaemia inhibitory factor (LIF) and its receptor (Aghajanova et al., 2003), 
progesterone (Stavreus-Evers et al., 2001) and integrin ǂVǃ3 (Lessey et al., 1992). Advocated 
as a marker of uterine receptivity, their expression, has been investigated solely by means of 
scanning electron microscopy (SEM) (Develioglu et al., 2000). 
2.4.2 Integrins 
Integrins are surface ligands, usually glycoproteins, belonging to the class of cell adhesion 
molecules (CAM). An integrin molecule consists of two different, non-covalently linked ǂ 
and ǃ subunits that are paired to form various heterodimers with distinct function (Hynes, 
2002). At least 20 types of integrin heterodimer have been defined, which form from 14ǂ and 
9ǃ subunits (Lindhard 2002). Integrins are unusual cell surface receptors in that they bind 
with low affinity and are present in large numbers, allowing for ligand motility without loss 
of attachment. Endometrial epithelial cells constitutively express certain integrins, whereas 
others are cycle dependent (Lessey 1992). ǂvǃ3, an example of the latter is present on the 
apical surface of both luminal endometrial cells and human embryos. 41 different aberrant 
expressions of this integrin are reported in women with endometriosis (Lessey et al., 1994).  
2.4.3 LIF 
LIF is a member of the IL-6 family and is secreted by the endometrial epithelium, CD16–
CD56 natural killer cells and type 2 T-helper cells. Animal and human studies indicate that 
LIF plays an important role in implantation and for pregnancy to occur (Lass et al., 2001). 
LIF protein can be detected by immunohistochemistry in the luminal, glandular and stromal 
epithelium. There is very little LIF expression in proliferative endometrium, but levels 
increase during the secretory phase, reaching a maximum between days 19 and 25, which 
coincides with the implantation window (Charnock-Jones 1994). 
2.4.4 Mucins  
Mucins are high molecular weight (MW) glycoproteins, which contain at least 50% of 
carbohydrate O-linked to a threonine/serine rich peptide core (Gendler et al., 1990). Among 
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the 14 cloned human mucins, only Mucin-1 (MUC1) and to a lesser extent MUC6 have been 
found in the human endometrium (Gipson et al., 1997). Cell–cell and cell–matrix adhesion 
are inhibited in direct correlation to the length of the MUC-1 ectodomain (Hilkens et al., 
1992; Wesseling et al., 1996). 
2.4.5 L-Selectin ligand  
Selectins are glycoproteins which also belong to the CAM family. The expression of selectin 
oligosaccharide-based ligands, such as MECA-79 or HECA-452, is up-regulated during the 
window of implantation (Genbacev et al., 2003). MECA-79 is immunolocalized in the 
luminal and glandular endometrial epithelium throughout the menstrual cycle, although the 
staining considerably intensifies during the mid-secretory phase. The physiological 
importance of the interaction between L-selectin and its oligosaccharide ligands has been 
investigated in the human endometrium (Genbacev et al., 2003).  
Though several studies investigating endometrial receptivity during implantation 
window are documented, the mechanism responsible for implantation failure in 
endometriosis is still poorly understood. Expression of various cell adhesion molecules 
and pinopodes in women with endometriosis is explored in the present study. Since, 
COX-2 is reported to be physiologically involved in the process of angiogenesis 
(Matsumoto et al., 2002), and in view of the fact that angiogenesis is essential for 
endometrial remodeling, we were motivated to assess the expression of various 
angiogenic factors including VEGFR, MMP-2,-9 and their tissue inhibitors in women with 
endometriosis during the implantation window. Additionally, expression of COX-2 was 
studied to assess their associated regulatory role in the process of endometrial remodeling 
during implantation window. 
2.5 Material and method  
2.5.1 Subject selection 
30 women with endometriosis and 20 without the disease were included in the study. 
Presence/absence of endometriosis was confirmed by diagnostic laparoscopy. It was 
ensured that these women had not received any kind of medical or hormonal treatment 
during the past three months. Women with history of chocolate cyst removal, previous 
history of any surgery, with other possible causes of pain or pelvic pathology including 
pelvic tuberculosis were excluded.  
2.5.2 Sample collection  
Blood samples collected from patients were allowed to clot and the serum separated by 
centrifugation at 3,000 rpm for 5 min at 4°C. Serum samples were stored at -20°C until 
further use. Endometrial biopsy was performed on the 7th day after confirmation of 
ovulation. The collected tissue was washed in phosphate buffer saline (PBS) and divided 
into three parts: one part was used for stromal and epithelial cells isolation for flow 
cytometric analysis of different molecular repertoires of the endometrium, the other part 
was fixed for immunohistochemistry (IHC) and scanning electron microscopy of these 
receptivity markers. From the third part, RNA was isolated immediately.  
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2.5.3 Isolation of cells and flow cytometric analysis  
Endometrial tissue was first digested in 2% collagenase-1 (Invitrogen, Grand Island, NY, USA) 
in DMEM (Himedia, Mumbai, India) for 1.5 to 2 hrs at 37°C and then centrifuged to isolate the 
stromal cells. Undigested glands were then treated with 0.25% trypsin-0.02% EDTA (Himedia, 
Mumbai, India) for 4–8min, washed with 10% FBS-DMEM. Single epithelial cells were isolated 
by centrifugation, as described previously. Isolated cells were washed, RBC lysed using RBC 
lysis solution and fixed in 2% paraformaldehyde (20 min at RT). Single cell suspension thus 
obtained was divided into five parts; four parts were stained with mouse anti-human ǂvǃ3 
integrin, LIF (R&D Systems, Minneapolis, MN, USA), Muc-1 (Abcam, Cambridge, UK) and rat 
anti-human MECA-79 monoclonal antibody (Santa Cruz 1 Biotechnology, Inc., Santa Cruz, 
California, USA) according to instructions provided by the manufacturer in the manual. The 
fifth part remained unstained. Excess antibodies were washed out and the cells again 
incubated with fluorescein conjugated secondary goat anti-mouse and anti-rat IgG (R&D 
Systems, Minneapolis, MN, USA). After washing excess antibodies, the stained cells were 
analyzed using flow cytometer (BD FACS Calibur™, BD Biosciences, San Jose, CA, USA).  
2.5.4 Immunohistochemistry 
3-5 µm thick sections obtained from formaldehyde fixed, paraffin-embedded tissue were 
dehydrated in graded ethanol. After antigen retrieval, slides were blocked using 3% BSA in 
PBS and incubated with mouse anti-human ǂvǃ3 integrin (R&D Systems, Minneapolis, MN, 
USA), Muc-1 (Abcam, Cambridge, UK), LIF and rat anti-human MECA-79 monoclonal 
antibody (Santa Cruz biotechnology, INC., Santa Cruz, California, USA). Excess primary 
antibody was washed with PBS and the sections were again incubated with anti-mouse and 
anti-rat biotinylated secondary antibody (Santa Cruz biotechnology, INC., Santa Cruz, 
California, USA) according to the manufacturer’s protocol, before incubation with avidin 
biotinylated horseradish peroxidase (Santa Cruz biotechnology, INC., Santa Cruz, 
California, USA). Labeled cells were visualized with Diaminobenzidine (DAB) and sections 
counterstained with hematoxylin. Next, the slides were dehydrated using series of alcohol 
gradient and mounted using distrene, tricresyl phosphate (DPX) and xylene. The slides were 
then examined under bright field microscope (Carl Zeiss, Jena, Germany).  
2.5.5 Scanning electron microscopy  
Formaldehyde-fixed tissues were washed in PBS and dehydrated in a series of alcohol 
gradient (50%, 70%, 90%, 95%, 100%), each for 10 mins, dipped in HMDS (1,1,1,3,3,3-
hexamethyl disilazane; SRL, Bombay, India) and air dried. Dried tissues were then mounted 
and coated with gold and the luminal endometrial surface thoroughly examined under SEM 
(Jeol JSM-5800 Scanning Microscope, Tokyo, Japan). Pinopode formation was also evaluated 
semi-quantitatively depending on their stage of development on the surface of the 
endometrium, and scored as (i) well-developed (ii) poorly developed and (iii) absent and on 
their abundance and scored as (i) abundant (ii) moderate (iii) few. 
2.5.6 Real-time PCR  
Levels of COX-2, MMP-2, -9, TIMP-1 and -2 gene expression were analyzed by real time 
PCR (RT-PCR), which was performed with ABI Prism 7000 Sequence Detection System 
(Applied  Biosystems Inc., Carlsbad, California, USA) using syber green master mix 
(Applied Biosystems Inc., Carlsbad, California, USA). RT-PCR primers were designed using 
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sequence data. Total RNA was isolated from tissue by RNA isolation kit (Trizol Reagent, 
Invitrogen, Carlsbad, California, USA) and 10 μl of total RNA isolated was subjected to 
reverse transcription for cDNA synthesis with High-Capacity cDNA Reverse Transcription 
Kits (Applied Biosystems, Carlsbad, California, USA), according to the manufacturer's 
instructions. After synthesis, 5 μl of cDNA was used for the RT-PCR mixed with syber 
green. At the end of each reaction, Cycle threshold (Ct) was manually set at the level that 
reflected the best kinetic PCR parameters, and melting curves were acquired and analyzed. 
Relative quantification was used to measure gene expression by relating the PCR signal. 
2.5.7 Western blotting  
The endometrial tissue was homogenized in tissue lysis buffer. The tissue lysate was then 
centrifuged at 15,000 g for 15 min and the protein concentration of the homogenates was 
determined by the GeNei™ Protein Estimation Kits (Bangalore Genei, India). 30 µg of 
homogenate protein were separated by SDS-polyacrylamide gel electrophoresis (SDS- PAGE). 
The separated proteins were electroblotted onto a Hybond PVDF membrane (GE Healthcare) 
at 30 volt for 13 hrs. After blocking the non-specific binding sites with non-fat dry milk in 
TBST buffer for 1 hr at room temperature, the blots were incubated overnight at 4°C with 
rabbit polyclonal antibody against COX-2, mouse monoclonal antibody against MMP-2,-9, 
TIMP-1 and -2 (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA), rabbit polyclonal 
antibody against VEGF, VEGFR1+VEGFR2 (Abcam, Cambridge, UK). The blots were then 
washed three times with TBST buffer, incubated for 1 hr at room temperature with 
horseradish peroxidase-linked goat anti-rabbit immunoglobulin G (IgG) and goat anti-mouse 
immunoglobulin G (IgG) (Santa Cruz Biotechnology Inc, Santa Cruz, CA, USA). After further 
washing, the immunoreactive proteins were revealed using the DAB as substrate.  
2.5.8 Statistical analysis  
Data were compared using independent two sample‘t’ test and chi-square test, as 
applicable. Ky Plot version 2.0 beta 13 software and Graphpad Prism Software were used for 
this purpose. Statistical significance was defined as p≤0.05. 
3. Result 
The clinical characteristics such as age, BMI, endometrial thickness, serum estrogen and 
progesterone levels of women participating in this study are summarized in Table I.  
 
Parameters Endometriosis Control P value 
Age 29.5±0.61 29.32±0.83 P>0.05 
BMI 28.18 ± 0.7 26.51 ± 0.6 P>0.05 
Endometrial thickness (cm) 9.25 ± 0.25 8.25 ± 0.41 P>0.05 
Serum estrogen level (pg/ml) 258.5 ± 13.83 193.6 ± 14.66 P≤0.05 
Serum progesterone level (ng/ml) 12.39 ± 1.28 26.43 ± 2 P≤0.05 
(Mean ± SEM) 
Table 1. 
Low levels of immunoreactivity of the endometrial receptivity markers including ǂvǃ3 
integrin, LIF, L-selectin ligands (MECA-79) and Muc-1 were observed in women with 
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endometriosis in contrast to strong immunoreactivity of controls. In addition, mean 
expression of these molecular markers detected by flow cytometric analysis shows a 
significantly lower expression both by the stromal and epithelial cells in women with 
endometriosis as compared to controls. 
 
Fig. 1. Immunohistological images of different biochemical markers expression.  
a. ǂvǃ3 integrins in control  b. ǂvǃ3  integrins in women with endometriosis c. Graphical 
representation of ǂvǃ3 integrin expression in  the stromal and epithelial cells of endometrial 
tissues in endometriosis and control d. LIF in control e. LIF in women with endometriosis 
f. Graphical representation of LIF expression in  the stromal and epithelial cells of endometrial 
tissues in endometriosis and control g. L-selectin ligand in control  h. L-selectin ligand in 
women with endometriosis i. Graphical representation of L-selectin ligand expression in  the 
stromal and epithelial cells of endometrial tissues in endometriosis and control  j. Muc1 in 
control  k. Muc1 in women with endometriosis l. Graphical representation of Muc1 expression 
in  the stromal and epithelial cells of endometrial tissues in endometriosis and control. 
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Further, few poorly developed pinopodes were seen in women with endometriosis as 
compared to controls, which showed abundant well formed pinopodes (Figure 2, 3 and 4). 
            
Fig. 2. Well developed pinopodes in control 
         
Fig. 3. Poorly developed pinopodes in endometriosis 
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Fig. 4. Graphical representation of pinopode expression in the endometrial tissues in 
endometriosis and controls. 
A significant increase in endometrial MMP-2, -9 and decrease in TIMP-1 and -2 expressions, 
were observed in women with endometriosis when compared to controls. Further, the 
endometrial expression of COX-2 was observed to be higher in women with endometriosis 
when compared with controls.     
       
Fig. 5. Expression of MMP-2 gene in endometriosis and control 
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Fig. 6. Expression of TIMP-2 gene in endometriosis and control 
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Fig. 7. Expression of MMP-9 gene in endometriosis and control      
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Fig. 8. Expression of TIMP-2 gene in endometriosis and control  
 
 
              
Fig. 9. Expression of MMP-2 and -9 in endometriosis and control 
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Fig. 10. Expression of TIMP-1 and -2 in endometriosis and control 
 
 
 
 
Fig. 11. Expression of COX-2 gene in endometriosis and control       
 
 
 
 
Fig. 12. Expression of COX-2 in endometriosis and control 
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Fig. 13. Expression of VEGFR-1 gene in endometriosis and controls 
 
Fig. 14. Expression of VEGFR-2 gene in endometriosis and controls  
 
Fig. 15. Expression of endometrial VEGF in endometriotic women and control 
 
Fig. 16. Expression of endometrial VEGFR in endometriotic women and control 
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Endometrial expression of VEGF and its receptors VEGFR1 and VEGFR2 were observed to be 
lower and higher respectively in women with endometriosis when compared with controls.  
4. Proposed molecular mechanism for implantation failure in endometriosis 
and future treatment strategies 
In the present study, a hypothesis correlating various factors responsible for implantation 
failure in endometriosis is proposed (Figure 16). It is well established that endometriosis is 
an estrogen-dependent disorder. As mentioned earlier, estrogen regulates the expression of 
MMP-2 and MMP-9 in matrix turnover and VEGF mediated angiogenic activities in various 
physiological and pathological conditions. Based on our findings, we hypothesize that 
dysregulation of sex steroids induces over-expression of COX-2 in the endometrium of 
women with endometriosis. This, in turn, affects endometrial remodelling by up-regulating 
the expression of MMP-2 and -9, the major molecules responsible for matrix degradation 
and also increases the expression of VEGF and its receptors, considered to be key angiogenic 
molecules.  This hypothesis is further evidenced by abnormal expression of implantation 
markers in these women suggesting poor endometrial receptivity and high rate of 
implantation failure. Molecules which can effectively control excessive endometrial matrix 
degradation by inhibiting over-expression of various factors responsible for matrix turnover 
and angiogenesis may be considered as a new therapeutic option for the treatment of 
endometriosis.  
 
Fig. 16. Schematic representation of the molecular mechanism regulating the process of 
endometrial receptivity in endometriosis during implantation window   
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